Double knockdown of α1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC
2007

New Method to Create Non-Fucosylated Antibodies

publication Evidence: high

Author Information

Author(s): Imai-Nishiya Harue, Mori Katsuhiro, Inoue Miho, Wakitani Masako, Iida Shigeru, Shitara Kenya, Satoh Mitsuo

Primary Institution: Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.

Hypothesis

Can established antibody-producing cells be converted to produce fully non-fucosylated antibodies to enhance their therapeutic efficacy?

Conclusion

The study demonstrates that double knockdown of FUT8 and GMD can effectively produce therapeutic antibodies that lack core fucosylation and exhibit enhanced antibody-dependent cellular cytotoxicity (ADCC).

Supporting Evidence

  • The study showed that single-gene knockdown was insufficient to eliminate fucosylation.
  • Double knockdown of FUT8 and GMD resulted in a significant increase in non-fucosylated antibodies.
  • The converted cells maintained high productivity of non-fucosylated antibodies in serum-free culture.

Takeaway

Scientists found a way to change cells so they make better antibodies for fighting cancer by removing a sugar that makes them less effective.

Methodology

The study used RNA interference to knock down FUT8 and GMD in CHO cells and selected for non-fucosylated antibody producers.

Limitations

The study primarily focused on two genes and may not account for other factors influencing fucosylation.

Digital Object Identifier (DOI)

10.1186/1472-6750-7-84

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication